Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT.
about
Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.New interleukin-15 superagonist (IL-15SA) significantly enhances graft-versus-tumor activity.Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.Early Reconstitution of NK and γδ T Cells and Its Implication for the Design of Post-Transplant Immunotherapy.Restoring T Cell Homeostasis After Allogeneic Stem Cell Transplantation; Principal Limitations and Future Challenges.
P2860
Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCT.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Interleukin-15 administration ...... loidentical hematopoietic SCT.
@en
Interleukin-15 administration ...... loidentical hematopoietic SCT.
@nl
type
label
Interleukin-15 administration ...... loidentical hematopoietic SCT.
@en
Interleukin-15 administration ...... loidentical hematopoietic SCT.
@nl
prefLabel
Interleukin-15 administration ...... loidentical hematopoietic SCT.
@en
Interleukin-15 administration ...... loidentical hematopoietic SCT.
@nl
P2093
P2860
P356
P1476
Interleukin-15 administration ...... ploidentical hematopoietic SCT
@en
P2093
C S Biswas
C T Sauter
N Flomenberg
O Alpdogan
T Budak-Alpdogan
P2860
P2888
P304
P356
10.1038/BMT.2013.47
P407
P577
2013-04-29T00:00:00Z